Oxford Pharmascience Group (OXP)


Latest News

Update regarding OXPzeroTM Ibuprofen Programmes

RNS Number: 5321E Oxford Pharmascience Group PLC 09 May 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Update regarding OXPzeroTM Ibuprofen Programmes Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, pr...

Miners drag on FTSE as commodity prices fall

Weaker commodity prices hit miners with Anglo American (AAL), Antofagasta (ANTO) and BHP Billiton (BLT) falling b...

Second Price Monitoring Extn

RNS Number: 1522B Oxford Pharmascience Group PLC 31 March 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-d...

FTSE falls on miners, financials as Old Mutual suffers

London shares were a little lower in early deals with heavyweight miners providing decisive ballast, but Old Mutual took t...

All News

09-05-17Update regarding OXPzeroTM Ibuprofen ProgrammesRNS
31-03-17Miners drag on FTSE as commodity prices fall StockMarketWire
31-03-17Second Price Monitoring ExtnRNS
31-03-17FTSE falls on miners, financials as Old Mutual suffersStockMarketWire
31-03-17Price Monitoring ExtensionRNS
31-03-17Oxford Pharmascience disappointed with FDA feedbackStockMarketWire
31-03-17FDA Feedback on OXPzeroT Ibuprofen Rx ProgrammeRNS
10-03-17Oxford Pharmascience narrows FY pretax lossStockMarketWire
10-03-17Final ResultsRNS
07-03-17Notice of ResultsRNS
23-02-17Company UpdateRNS
25-01-17Oxford Pharmascience - Company updateBRR Media
17-01-17Oxford Pharmascience issues company updateStockMarketWire
17-01-17Company UpdateRNS
09-11-16R&D UpdateRNS
19-10-16Here's what Neil Woodford is buying and sellingInteractive Investor
13-09-16Oxford Pharmascience - Interim results 2016BRR Media
07-09-16Interim results for the 6 months to 30 June 2016RNS
21-07-16Oxford Pharmascience downgraded by BeaufortStockMarketWire
21-07-16Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLCStockMarketWire
20-07-16FTSE rises on pharmas, financials as miners ebbStockMarketWire
20-07-16Commercial Update & Directorate ChangeRNS
22-06-16Result of AGMRNS
20-05-16Shares Magazine Investor Evening PresentationRNS
22-04-16OXP to exhibit at the Master Investor Show 2016RNS
22-04-16Oxford Pharmascience Group plc - Company updateBRR Media
19-04-16Positive Regulatory Advice from MHRARNS
11-03-16Grant of Share OptionsRNS
04-03-16Oxford Pharmascience widens FY pretax lossStockMarketWire
04-03-16Final ResultsRNS
01-03-16Oxford Pharmascience schedules FY results StockMarketWire
01-03-16Notice of ResultsRNS
25-02-16Appointment of DirectorRNS
29-01-16Change of Registered OfficeRNS
25-01-16OXP primed for partnering talks on OXPzero NSAIDSStockMarketWire
25-01-16Entering Partnering DiscussionsRNS
04-12-15Oxford Pharmascience CFO granted share optionsStockMarketWire
04-12-15Grant of Share OptionsRNS
01-12-15Holding(s) in CompanyRNS
05-11-15OXP updates on OXPzero Ibuprofen StockMarketWire

RSS feeds

  • Editorial news feed for LSE:OXP Editorial
  • Regulatory news feed for LSE:OXP Regulatory